Colgate-Palmolive (WKN: 850667) eine der konstantesten Wachstumssaktien (Seite 25)

[Larry.Livingston]

Unglaublich, kam jetzt erst auf die Idee nach einem Colgate Thread zu suchen.

Hier noch ein Fool Artikel:

Colgate-Palmolive Ends With a Winner
By Timothy M. Otte February 4, 2008
3 Recommendations

When you're having a great season, the mark of a real winner is the ability to close the deal in the fourth quarter. Simply stated, 2007 has been a winning year for Colgate-Palmolive (NYSE: CL). And as with most winners, it finished the year with a strong performance in the fourth quarter.

To understand the company's continued momentum, consider these growth rates for the fourth-quarter and full-year 2007. All numbers shown are excluding charges from the restructuring program begun in 2004:

Colgate-Palmolive Selected Growth Rates


QTR 4
12 Month
Change

Total sales
13.5%
12.7%
0.8%

Gross profit
15.3%
14.6%
0.9%

Operating income
17.7%
15.3%
2.4%

Earnings per share
16.7%
16.2%
0.5%


By every profit and loss measure that counts, fourth-quarter results show healthy acceleration from already-solid trends. The gross margin numbers are particularly noteworthy, as margins are expanding by 90 basis points during a time when other consumer product companies like Kraft Foods (NYSE: KFT), Kellogg (NYSE: K), and Kimberly-Clark (NYSE: KMB) are experiencing margin erosion. It's true that the product lineup and the specific raw materials these companies depend on are different. But even if Colgate is not experiencing quite the degree of cost inflation as these other companies, a 90-basis-point expansion in margins is impressive.

A key driver of this success was unit volume growth of 5.5% during the quarter and full-year unit volume expansion of 6.5%. The only laggard remains the Hill's pet nutrition segment, which has been growing more slowly than the company's other brands, and actually dipped into slightly negative unit volume growth in the fourth quarter. Total international sales grew at a much faster rate than North American sales because of favorable currency conversion rates.

So how do these fourth-quarter results stack up against Colgate's primary competitor, Procter & Gamble (NYSE: PG), which also reported quarterly results last week? Quite favorably, I would say. Volume growth was comparable, but Colgate delivered much higher total sales growth (13.5% vs. 9%), benefitting from a significantly larger percentage of its sales coming from overseas markets (that currency translation effect). Both companies delivered earnings-per-share growth of 17%.

The cream continues to rise to the top. I might give P&G a slight edge from a stock picking perspective because of the lower trailing-12-month P/E ratio of 22 compared to Colgate's 24. But Colgate is showing nice momentum. Either stock looks like a solid core portfolio choice to me at this point.

[1435905]

Wahnsinn! Heute morgen gab es CL für 44 EUR!!!
Hatte leider kein Kauflimit im Markt, das wär nen schöner Einstieg gewesen.

[spaceistheplace]

Antwort auf Beitrag Nr.: 32.977.052 von 1435905 am 08.01.08 11:10:36

Doch 1435905 , ich schreibe mal was, obwohl ich die Aktie nicht im Depot habe, dafür aber PG, die ja ähnlich sind. CL wie auch PG (habe da nen Thread) sind halt langweileraktien und für 98% der WO-Schreiberlinge hier, die aufs Zocken aus sind, nicht interessant.

Nicht nur im Geschäftsfeld, sondern auch vom Langfristchart her und auch der Divi, ist kaum ein Unterschied zwischen den beiden Unternehmen. CL scheint sich etwas konstanter zu entwickeln.
Ich habe mich für PG entschieden, weil mir einfach deren Produkte geläufiger sind und ich auch selbst benutze. hat nichts mit CL direkt zu tun.

Jedenfalls gehört eines der beiden Unternehmen in jedes Langfristdepot, denn die Qualität ist Stufe 1. In Europa findet man solche Unternehmen so gut wie nicht, höchstens L'Oreal.

Hier mal ein Chartvergleich seit 1971. PG hatte 2000 einen gewaltigen Einbruch, hat den aber wieder aufgeholt. Aktuell absolut gleich

Gruss space

[1435905]

Ist denn keiner da der sich mal zu Wort melden möchte? Schade
Es gibt doch auch sicher hier bei w:o Colgate Aktionäre oder Interessierte, bitte meldet euch!

[1435905]

Als Zusammenfassung meiner kurzen Recherche von gestern lässt sich sagen, dass Colgate - wenn man Wettbewerber und das eigene Wachstum heranzieht - derzeit sicherlich ambitioniert bewertet ist. In erster Line bietet sich dabei ein Vergleich mit PG an, da beide Unternehmen hinsichtlich Markenstärke und Kontinuität der Entwicklung vergleichbar sind.

[1435905]

Forbes Industry: Household & Personal Products
StarMine Industry: Household products
Analyst Name: Justin Hott
Brokerage: Bear Stearns

StarMine, a San Francisco research company that keeps extensive tabs on stock picks and earnings forecasts made by security analysts, rated Bear Stearns' Justin Hott No. 1 at picking stocks in household products. We spoke with Hott about the outlook for his industry in the coming year.

The Big Trend

Hott says that all the companies in this sector are looking for international markets for growth. The companies that are excelling are finding more markets and finding ways to get more growth out of them, like Procter & Gamble (nyse: PG - news - people ) in China, Colgate-Palmolive (nyse: CL - news - people ) in Latin America, Avon Products (nyse: AVP - news - people ) in Brazil and China, and Alberto-Culver (nyse: ACV - news - people ) in the U.K.


The Unconventional Wisdom

"Investors often want to buy a company based on the product but it is not always about the product," says Hott. "Just as important can be revamps to the organization or fresh ways of thinking about how the company does business. That has been a major key in Colgate's success, for example. It instituted something called Colgate Business Planning, which is a program to determine how to spend their funds more effectively. It's been a big innovation for them."

The Misplaced Assumption

"There is a misplaced assumption that the smaller players cannot compete with the bigger players. If you are focused on your product, come up with good marketing and advertising, and have a brand with a compelling story to investors, you can win, regardless of size." Hott cites Alberto-Culver, which has just $1.5 billion in latest 12-month revenues. "They have a couple of products, Tresemmé and Nexus that have worked very well. Even though they are not a Unilever or Procter & Gamble in terms of size, they have done very well in the areas they compete.”

The Watch List

Hott says to watch whether Procter & Gamble, the top company in its sector, can reinvigorate its beauty division. "It had been a great growth driver for many years but has been disappointing the past couple quarters." Avon is also on Hott's watch list. He is encouraged by some of the steps taken in its multiyear restructuring plan. "In 2008, many investors expect to see cost savings float down to earnings. The question is if they can get back to their pre-restructuring margins."

Hott is also keeping an eye on Estée Lauder Cos. (nyse: EL - news - people ). He says the company is at the beginning of some significant management changes, and is trading at an extremely cheap valuation for a prestige beauty company.

The Bold Prediction

Merger and acquisition activity is going to continue, according to Hott. Part of it will be companies looking for synergies and scale. Another part of it will be companies looking for products that can offer a great international platform in growth.

[1435905]

Das Dividendenwachstum von CL betrug in den letzten 10 Jahren durchschnittlich 10% p.a., ich halte das für ganz respektabel.

[1435905]

die Tabelle lässt sich leider nicht besser formatieren, aber sehr schön ist hier der Vergleich mit Procter:

DIRECT COMPETITOR COMPARISON
CL CHD CLX PG Industry
Market Cap: 39.68B 3.53B 8.84B 226.03B 80.15M
Employ­ees: 34,700 3,655 7,800 138,000 235
Qtrly Rev Growth (yoy): 12.20% 11.90% 6.70% 7.50% 7.50%
Revenue (ttm): 13.36B 2.17B 4.93B 77.89B 147.73M
Gross Margin (ttm): 57.08% 39.24% 43.11% 52.06% 57.08%
EBITDA (ttm): 3.06B 359.83M 1.11B 18.91B 8.67M
Oper Margins (ttm): 20.39% 13.99% 18.54% 20.30% 8.23%
Net Income (ttm): 1.70B 161.26M 495.00M 10.56B 3.43M
EPS (ttm): 3.158 2.355 3.288 3.168 0.67
P/E (ttm): 24.65 22.74 19.40 22.97 22.64
PEG (5 yr expected): 2.12 1.72 1.77 1.6 1.63
P/S (ttm): 2.95 1.62 1.80 2.88 1.56
CHD = Church & Dwight Co. Inc.
CLX = Clorox Co.
PG = Procter & Gamble Co.
Industry = Personal Products

[1435905]

Zacks.com
Colgate Better Long-Term
Monday December 17, 11:33 am ET
By Steven Ralston, CFA

A Hold recommendation has recently been issued to oral and personal care company Colgate-Palmolive Company (NYSE: CL - News) by Zacks senior consumer products analyst Steven Ralston, CFA. Here\'s what his latest update had to say:

ADVERTISEMENT
\'Colgate-Palmolive has had a stellar long-term growth record. The company's tight financial controls and history of new product innovations coupled with efforts to enhance shareholder value through share repurchases and dividend increases support a positive long-term view on the stock. However, competition in Europe, especially Germany, rising raw material/fuel costs, and the costs related to the implementation of the restructuring plan remain concerns.

\'Company stock has traded in a P/E multiple range of 18 to 27 over the last four years. However, during the last time of earnings de-acceleration and a corporate restructuring in the mid-1990s, Colgate's stock traded at a P/E in the low 20s. The stock is currently trading at a P/E multiple of 24.8, which is in the middle of the historical range. Positive earning surprises along with savings from the company's restructuring and business-building plan should support future growth.

\'In addition, the company remains the clear market leader in the oral care segment. With an array of new products scheduled to be launched in 2007 and an ahead-of-schedule restructuring plan, the company should deliver positive results. However, aggressive advertising expenditures and a challenging European environment should continue to constrain near-term growth. Therefore, the stock is rated a Hold. The target price of $87.75 is based on a 27 P/E on 12-month trailing earnings.\'

[1435905]

Die Colgate-Palmolive Company ist ein globaler Hersteller von Zahnpasta und Haushaltshygiene. Das Unternehmen vermarktet seine Produkte unter international bekannten Markennamen wie "Colgate", "Palmolive", "Ajax" und "Mennen". Colgate produziert und vertreibt eine Vielzahl von Produkten in den beiden unterschiedlichen Segmenten Mund-, Körper- und Haushaltspflegemittel sowie Tiernahrung. Die Mund-, Körper- und Haushaltspflegemittel umfassen Zahnpasta, Mundspülungen und Zahnbürsten, Seife, Shampoos, Haarpflegemittel, Deodorants, Reinigungsmittel und -geräte, Bleichmittel, Wasch- und Geschirrspülmittel sowie verwandte Produkte. Die Colgate & Company wurde 1806 in New York gegründet und fusionierte 1828 mit Palmolive Peet Company. Der heutige Firmenname entstand erst 1953.